Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP835068.RAZFOYMQqQk2m2RlH1VqTMW2FTTHkJtkTm3CQGFi1Zvvg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP835068.RAZFOYMQqQk2m2RlH1VqTMW2FTTHkJtkTm3CQGFi1Zvvg130_assertion type Assertion NP835068.RAZFOYMQqQk2m2RlH1VqTMW2FTTHkJtkTm3CQGFi1Zvvg130_head.
- NP835068.RAZFOYMQqQk2m2RlH1VqTMW2FTTHkJtkTm3CQGFi1Zvvg130_assertion wasGeneratedBy ECO_0000203 NP835068.RAZFOYMQqQk2m2RlH1VqTMW2FTTHkJtkTm3CQGFi1Zvvg130_provenance.
- NP835068.RAZFOYMQqQk2m2RlH1VqTMW2FTTHkJtkTm3CQGFi1Zvvg130_assertion wasDerivedFrom befree-2016 NP835068.RAZFOYMQqQk2m2RlH1VqTMW2FTTHkJtkTm3CQGFi1Zvvg130_provenance.
- NP835068.RAZFOYMQqQk2m2RlH1VqTMW2FTTHkJtkTm3CQGFi1Zvvg130_assertion SIO_000772 20739657 NP835068.RAZFOYMQqQk2m2RlH1VqTMW2FTTHkJtkTm3CQGFi1Zvvg130_provenance.
- NP835068.RAZFOYMQqQk2m2RlH1VqTMW2FTTHkJtkTm3CQGFi1Zvvg130_assertion evidence source_evidence_literature NP835068.RAZFOYMQqQk2m2RlH1VqTMW2FTTHkJtkTm3CQGFi1Zvvg130_provenance.
- NP835068.RAZFOYMQqQk2m2RlH1VqTMW2FTTHkJtkTm3CQGFi1Zvvg130_assertion description "[We investigated in vitro sensitivity to the poly (ADP-ribose) polymerase inhibitor olaparib (AZD2281) of 5 ATM mutant lymphoblastoid cell lines (LCL), an ATM mutant MCL cell line, an ATM knockdown PGA CLL cell line, and 9 ATM-deficient primary CLLs induced to cycle and observed differential killing compared with ATM wildtype counterparts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP835068.RAZFOYMQqQk2m2RlH1VqTMW2FTTHkJtkTm3CQGFi1Zvvg130_provenance.